GLP-1, SGLT-2, new devices for interventional cardiologists

Código QR

GLP-1, SGLT-2, new devices for interventional cardiologists

Guardado en:

Detalles Bibliográficos
Autor principal:	Çetin Erol
Formato:	article
Lenguaje:	EN
Publicado:	KARE Publishing 2021
Materias:	Diseases of the circulatory (Cardiovascular) system RC666-701
Acceso en línea:	https://doaj.org/article/4630f1be8e764fc0845583d177fc65ad
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Carotid artery stenting, new devices and techniques for interventional cardiology and atrial fibrillation
por: Çetin Erol
Publicado: (2021)

An updated perspective and pooled analysis of cardiovascular outcome trials of GLP-1 receptor agonists and SGLT-2 inhibitors
por: Mustafa Kılıçkap, et al.
Publicado: (2021)

New impact factor and many new studies
por: Çetin Erol
Publicado: (2021)

A Practical Guide for Cardiologists to the Pharmacological Treatment of Patients with Type 2 Diabetes and Cardiovascular Disease
por: Tariq Ahmad, et al.
Publicado: (2021)

Pregnancy in Women with Congenital Heart Disease: A Guide for the General Cardiologist
por: Catherine R Weinberg, et al.
Publicado: (2020)

New year and our 20th Anniversary, Thomas F. Lüscher, pulmonary hypertension
por: Çetin Erol
Publicado: (2021)

Novel Pharmacological Treatment of Patients with Type 2 Diabetes and Cardiovascular Disease: What Cardiologists and Diabetologists Should Know
por: Felipe Martínez
Publicado: (2021)

What cardiologists need to know about cardiovascular magnetic resonance (CMR)
por: J. Cameron Bridgman, et al.
Publicado: (2017)

What is the Real Message of the International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) Trial for Academic and Practising Cardiologists?
por: Kreton Mavromatis, et al.
Publicado: (2020)

Studies and Reviews on Central Sleep Apnea, Endovascular Therapy, Robotic Surgery, and the associated Clinical and Genetic Characteristics in Cardiology
por: Çetin Erol
Publicado: (2021)

Ramadan, TURKMI, REALITY HF, and so on…0
por: Çetin Erol
Publicado: (2021)

Colchicine, fragmented QRS, coronavirus disease 2019, and more
por: Çetin Erol
Publicado: (2021)

Energy drinks, pulmonary hypertension, and many more
por: Çetin Erol
Publicado: (2021)

Miscellaneous attractive studies
por: Çetin Erol
Publicado: (2021)

ARNI, LBBB, COVID-19 and various other topics
por: Çetin Erol
Publicado: (2021)

Adipositas Cordis or Cor Adiposum: A rarely recognized entity every cardiologist should be aware of!
por: Vijayachandra Y Reddy, et al.
Publicado: (2021)

Effects of SGLT-2 inhibitor on myocardial fibrosis and left ventricular reverse remodeling
por: Dipak Katare, et al.
Publicado: (2021)

Choosing Between Left Ventricular Assist Devices and Biventricular Assist Devices
por: Sajad Shehab, et al.
Publicado: (2019)

Heart Failure Treatment by Device
por: Antoni Bayés-Genis
Publicado: (2020)

Implantable Cardiac Electronic Devices in the Elderly Population
por: Wei-Yao Lim, et al.
Publicado: (2019)

Calcified Lesion Assessment and Intervention in Complex Percutaneous Coronary Intervention: Overview of Angioplasty, Atherectomy, and Lithotripsy
por: Alexander G Truesdell, et al.
Publicado: (2020)

Increasing and Evolving Role of Smart Devices in Modern Medicine
por: Michael R Massoomi, et al.
Publicado: (2019)

Is air travel safe for patients with cardiac implantable electronic devices?
por: Aycan Fahri Erkan
Publicado: (2021)

The Association of Atrial Fibrillation Before Percutaneous Coronary Intervention With 1-Year Outcome in ST-Elevation Myocardial Infarction Patients
por: Eero Anttonen, MD, et al.
Publicado: (2021)

Percutaneous Coronary Intervention for Chronic Total Occlusion
por: Giovanni Maria Vescovo, et al.
Publicado: (2020)

State-of-the-art Structural Interventions in Heart Failure
por: Jeffrey Park, et al.
Publicado: (2019)

Antithrombotic Therapy in Chronic Total Occlusion Interventions
por: Iosif Xenogiannis, et al.
Publicado: (2021)

Timing of Intervention in Asymptomatic Patients with Aortic Stenosis
por: Teresa Sevilla, et al.
Publicado: (2021)

Transcatheter Tricuspid Valve Intervention: Current Perspective
por: Trevor J Simard, et al.
Publicado: (2021)

Post percutaneous coronary intervention hemoglobin levels predict in-hospital mortality in patients with STEMI treated with primary percutaneous coronary intervention
por: Gönül Zeren, et al.
Publicado: (2021)

The Use of App-based Follow-up of Cardiac Implantable Electronic Devices
por: Paul Richard Roberts, et al.
Publicado: (2020)

Strategies to Reduce Radiation Exposure in Electrophysiology and Interventional Cardiology
por: Sandeep Shankar, et al.
Publicado: (2020)

Antithrombotic Treatment After Coronary Intervention: Agreement and Controversy
por: Tamara García Camarero, et al.
Publicado: (2020)

Percutaneous Coronary Intervention: Developments in the Last 12 Months
por: Rhian E Davies, et al.
Publicado: (2019)

Fatal Enterovirus-related Myocarditis in a Patient with Devic’s Syndrome Treated with Rituximab
por: Ava Diarra, et al.
Publicado: (2021)

Aortic Root Thrombus Directly After Left Ventricular Assist Device Implantation
por: Constantin Mork, MD, et al.
Publicado: (2021)

Peritoneal expression of SGLT-2, GLUT1 and GLUT3 in peritoneal dialysis patients
por: Severin Schricker, et al.
Publicado: (2021)

Destination Therapy with Left Ventricular Assist Devices in Non-transplant Centres: The Time is Right
por: Antoni Bayes-Genis, et al.
Publicado: (2020)

Hypothyroidism Is Associated With Longer Hospital Stay Following Implantation Of Left Ventricular Assist Device
por: Sakiru O Isa, et al.
Publicado: (2021)

Paclitaxel Exposure and Dosage of Drug-coated Devices for the Treatment of Femoropopliteal Peripheral Artery Disease
por: Ceazón T Edwards, et al.
Publicado: (2021)